That was a well put article and I think he hit it right on the head with KERX. I do dissagree with the fact that they will raise dilutive capital by issueing share, it has been stated as of late, KERX is well capitalized into 2011. Meaning they have enough money to bRing the two drugs to market WITHOUT FURTHER DILUTION!!!. There has been nothing but good news on this stock...SPA, Orphan Drug Status,etc. FDA is behind this one. Also check out BVTI, ABPIQ, IMMU